Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Reynes

Showing results (131-140 of 200) with videos related to

Pageof 20
Sort By:
JAMA Otolaryngology-- Head & Neck Surgery|January 7, 2021
Diagnostic Value of Patient-Reported and Clinically Tested Olfactory Dysfunction in a Population Screened for COVID-19Charles Villerabel, Alain Makinson, Audrey Jaussent, et al.
AIDS (London, England)|July 14, 2018
Determinants of high-grade anal intraepithelial lesions in HIV-positive MSMGary M Clifford, Laurent Siproudhis, Lionel Piroth, et al.
AIDS (London, England)|August 6, 2015
Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in AfricaLaura Ciaffi, Sinata Koulla-Shiro, Adrien Sawadogo, et al.
Science (New York, N.Y.)|February 27, 2007
Suppression of microRNA-silencing pathway by HIV-1 during virus replicationRobinson Triboulet, Bernard Mari, Yea-Lih Lin, et al.
The Journal of Antimicrobial Chemotherapy|June 28, 2022
Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trialAntoine Chéret, Rebecca Bauer, Vincent Meiffrédy, et al.
AIDS (London, England)|April 24, 2018
A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patientsJoseph J Eron, Chloe Orkin, Joel Gallant, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2011
Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort studyAlain Makinson, Jean-Charles Tenon, Sabrina Eymard-Duvernay, et al.
AIDS (London, England)|November 26, 2019
Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infectionRaphael Veil, Isabelle Poizot-Martin, Jacques Reynes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2015
Chest Low-Dose Computed Tomography for Early Lung Cancer Diagnosis as an Opportunity to Diagnose Vertebral Fractures in HIV-Infected Smokers, an ANRS EP48 HIV CHEST SubstudyYann Thouvenin, Alain Makinson, Amandine Cournil, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2014
Simeprevir (TMC435) with pegylated interferon/ribavirin in patients coinfected with HCV genotype 1 and HIV-1: a phase 3 studyDouglas Dieterich, Jürgen Kurt Rockstroh, Chloe Orkin, et al.
Pageof 20

Showing results (131-140 of 200) with videos related to

Sort By:
Pageof 20
JAMA Otolaryngology-- Head & Neck Surgery|January 7, 2021
Diagnostic Value of Patient-Reported and Clinically Tested Olfactory Dysfunction in a Population Screened for COVID-19Charles Villerabel, Alain Makinson, Audrey Jaussent, et al.
AIDS (London, England)|July 14, 2018
Determinants of high-grade anal intraepithelial lesions in HIV-positive MSMGary M Clifford, Laurent Siproudhis, Lionel Piroth, et al.
AIDS (London, England)|August 6, 2015
Efficacy and safety of three second-line antiretroviral regimens in HIV-infected patients in AfricaLaura Ciaffi, Sinata Koulla-Shiro, Adrien Sawadogo, et al.
Science (New York, N.Y.)|February 27, 2007
Suppression of microRNA-silencing pathway by HIV-1 during virus replicationRobinson Triboulet, Bernard Mari, Yea-Lih Lin, et al.
The Journal of Antimicrobial Chemotherapy|June 28, 2022
Once-daily dolutegravir versus darunavir plus cobicistat in adults at the time of primary HIV-1 infection: the OPTIPRIM2-ANRS 169 randomized, open-label, Phase 3 trialAntoine Chéret, Rebecca Bauer, Vincent Meiffrédy, et al.
AIDS (London, England)|April 24, 2018
A week-48 randomized phase-3 trial of darunavir/cobicistat/emtricitabine/tenofovir alafenamide in treatment-naive HIV-1 patientsJoseph J Eron, Chloe Orkin, Joel Gallant, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 23, 2011
Human immunodeficiency virus infection and non-small cell lung cancer: survival and toxicity of antineoplastic chemotherapy in a cohort studyAlain Makinson, Jean-Charles Tenon, Sabrina Eymard-Duvernay, et al.
AIDS (London, England)|November 26, 2019
Virological and immunological impact of integrase inhibitor-based regimens initiated during primary HIV-1 infectionRaphael Veil, Isabelle Poizot-Martin, Jacques Reynes, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 10, 2015
Chest Low-Dose Computed Tomography for Early Lung Cancer Diagnosis as an Opportunity to Diagnose Vertebral Fractures in HIV-Infected Smokers, an ANRS EP48 HIV CHEST SubstudyYann Thouvenin, Alain Makinson, Amandine Cournil, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 7, 2014
Simeprevir (TMC435) with pegylated interferon/ribavirin in patients coinfected with HCV genotype 1 and HIV-1: a phase 3 studyDouglas Dieterich, Jürgen Kurt Rockstroh, Chloe Orkin, et al.
Pageof 20